Show results for
Refine by
Innate Immunity Services In Europe
5 services found
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
Natural autoantibody (NAA) represents a substantial proportion of the normal antibodies, and contributes to the stimulation of primitive innate immune system. Using NAA biomarkers to achieve early diagnosis of infectious disease is promising and can reflect clinical responses to immunotherapy. Empowered by our advanced high-resolution analytical platforms and ...
Manufactured by:Creative Bioarray based inShirley, NEW YORK (USA)
They have various forms throughout the body, such as histiocytes, Kupffer cells, alveolar macrophages, microglia, etc., but all are part of the mononuclear phagocyte system. In addition to phagocytosis, they play a key role in non-specific defense (innate immunity) and also help to initiate specific defense mechanisms (adaptive immunity) by ...
Manufactured by:Creative Bioarray based inShirley, NEW YORK (USA)
Kupffer cells are resident liver macrophages and play a critical role in maintaining liver function. Under physiological conditions, they are the first innate immune cells that protect the liver from bacterial infection. Under pathological conditions, they are activated by different components and can differentiate into M1-like (classical) or M2-like ...
Manufactured by:Creative Bioarray based inShirley, NEW YORK (USA)
Kupffer cells are resident liver macrophages and play a critical role in maintaining liver function. Under physiological conditions, they are the first innate immune cells that protect the liver from bacterial infection. Under pathological conditions, they are activated by different components and can differentiate into M1-like (classical) or M2-like ...
Manufactured by:Kiadis Pharma NV based inAmsterdam, NETHERLANDS
Innovative antibody-based molecular concepts. New treatments for cancer that leverage our own immune system to attack and destroy cancer cells can provide long-term and durable therapeutic responses in patients suffering from life-threatening malignancies. These benefits for patients have been driven by recently developed therapeutic antibodies binding with high specificity to drug targets on ...